Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

The 4th U.S. Circuit Court of Appeals on Thursday blocked the enforcement of the Trump administration's rules that prohibit taxpayer-funded family planning clinics under the Title X program in Maryland from providing or making abortion referrals.

Why it matters: Thursday's decision in the Virginia-based federal court is at odds with a ruling in the California-based 9th U.S. Circuit Court of Appeals, which upheld the rules and allowed them to take effect. The division means the Supreme Court may be more likely to take up the issue.

What they're saying: The 4th U.S. Circuit Court of Appeals ruled that the Trump administration "failed to recognize and address the ethical concerns of literally every major medical organization in the country," and "arbitrarily estimated the cost" to clinics in implementing the rules.

Context: Title X is a $286 million federal family planning program that primarily serves low-income individuals.

  • Last year, Planned Parenthood and some states withdrew from the program to avoid complying with the Trump administration's rule changes.
  • Abortion rights supporters have referred to the changes as a "gag rule," saying the orders hurt the relationship between women and their doctors, who have to limit the information they can provide. They also say the rules would force some abortion providers to shut down or undergo expensive remodels, hurting access to reproductive health services broadly.
  • Abortion rights opponents have long argued that the Title X program indirectly subsidizes abortion services. Providers were already barred from using federal funds for abortion services.

Of note: Thursday's decision, which involved a lawsuit by Baltimore's mayor and city council, only applies to the state of Maryland.

  • "Today’s ruling will continue to prevent this terrible rule from further harming family planning providers and their patients across the state of Maryland. Unfortunately, the court did not take the opportunity to bring the desperately needed relief to the nationwide family planning provider network that is appropriate under and required by federal law," Clare Coleman, president and CEO of the National Family Planning & Reproductive Health Association, said in a statement.

Go deeper: Read the 4th U.S. Circuit Court of Appeals' ruling.

Go deeper

Solv Health raises $27 million as health care providers move online

Illustration: Annelise Capossela/Axios

Solv Health, a startup that sells health care providers digital tools to manage patients, has raised $27 million in new funding led by Acrew Capital, with MultiCare Health System, Light Street Capital, Benchmark and Greylock Partners also participating.

Why it matters: Overnight, the ongoing pandemic significantly altered how people interact with the health care system, creating a need to reduce unnecessary in-person contact that has sped up the digital transformation of medical practice.

Scoop: USAID chief tests positive for coronavirus

An Air Force cargo jet delivers USAID supplies to Russia earlier this year. Photo: Mikhail Metzel/TASS via Getty Images

The acting administrator of the United States Agency for International Development informed senior staff Wednesday he has tested positive for coronavirus, two sources familiar with the call tell Axios.

Why it matters: John Barsa, who staffers say rarely wears a mask in their office, is the latest in a series of senior administration officials to contract the virus. His positive diagnosis comes amid broader turmoil at the agency following the election.

Bryan Walsh, author of Future
2 hours ago - Health

COVID-19 shows a bright future for vaccines

Illustration: Annelise Capossela/Axios

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!